vs
ASP Isotopes Inc.（ASPI）与EVERSPIN TECHNOLOGIES INC.（MRAM）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是EVERSPIN TECHNOLOGIES INC.的1.1倍（$16.7M vs $14.9M），ASP Isotopes Inc.同比增速更快（1295.7% vs 13.2%）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Everspin Technologies是一家总部位于美国亚利桑那州钱德勒的上市半导体企业，核心业务为研发生产磁阻随机存取存储器（MRAM）产品，涵盖Toggle MRAM与自旋转移矩MRAM两大产品系列，同时也对外授权嵌入式MRAM、磁传感器相关技术，并提供嵌入式MRAM后道代工服务。
ASPI vs MRAM — 直观对比
营收规模更大
ASPI
是对方的1.1倍
$14.9M
营收增速更快
ASPI
高出1282.5%
13.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $14.9M |
| 净利润 | — | $-296.0K |
| 毛利率 | 12.5% | 52.7% |
| 营业利润率 | — | 29.0% |
| 净利率 | — | -2.0% |
| 营收同比 | 1295.7% | 13.2% |
| 净利润同比 | -586.8% | — |
| 每股收益（稀释后） | — | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIMRAM
| Q1 26 | — | $14.9M | ||
| Q4 25 | $16.7M | $14.8M | ||
| Q3 25 | $4.9M | $14.1M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $12.1M | ||
| Q2 24 | — | $10.6M |
净利润ASPIMRAM
| Q1 26 | — | $-296.0K | ||
| Q4 25 | — | $1.2M | ||
| Q3 25 | $-12.9M | $54.0K | ||
| Q2 25 | — | $-670.0K | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $-2.5M |
毛利率ASPIMRAM
| Q1 26 | — | 52.7% | ||
| Q4 25 | 12.5% | 50.8% | ||
| Q3 25 | 8.7% | 51.3% | ||
| Q2 25 | — | 51.3% | ||
| Q1 25 | — | 51.4% | ||
| Q4 24 | — | 51.3% | ||
| Q3 24 | — | 49.2% | ||
| Q2 24 | — | 49.0% |
营业利润率ASPIMRAM
| Q1 26 | — | 29.0% | ||
| Q4 25 | — | -7.2% | ||
| Q3 25 | -306.1% | -11.0% | ||
| Q2 25 | — | -14.9% | ||
| Q1 25 | — | -14.7% | ||
| Q4 24 | — | -11.8% | ||
| Q3 24 | — | -17.5% | ||
| Q2 24 | — | -26.5% |
净利率ASPIMRAM
| Q1 26 | — | -2.0% | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | -263.7% | 0.4% | ||
| Q2 25 | — | -5.1% | ||
| Q1 25 | — | -8.9% | ||
| Q4 24 | — | 9.2% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | -23.5% |
每股收益（稀释后）ASPIMRAM
| Q1 26 | — | $-0.01 | ||
| Q4 25 | — | $0.05 | ||
| Q3 25 | $-0.15 | $0.00 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $40.5M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $70.2M |
| 总资产 | $498.0M | $83.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPIMRAM
| Q1 26 | — | $40.5M | ||
| Q4 25 | $333.3M | $44.5M | ||
| Q3 25 | $113.9M | $45.3M | ||
| Q2 25 | — | $45.0M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $42.1M | ||
| Q3 24 | — | $39.6M | ||
| Q2 24 | — | $36.8M |
总债务ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASPIMRAM
| Q1 26 | — | $70.2M | ||
| Q4 25 | $204.2M | $68.9M | ||
| Q3 25 | $74.1M | $65.8M | ||
| Q2 25 | — | $64.1M | ||
| Q1 25 | — | $63.0M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | — | $59.3M | ||
| Q2 24 | — | $55.4M |
总资产ASPIMRAM
| Q1 26 | — | $83.2M | ||
| Q4 25 | $498.0M | $84.6M | ||
| Q3 25 | $225.9M | $80.3M | ||
| Q2 25 | — | $78.9M | ||
| Q1 25 | — | $80.2M | ||
| Q4 24 | — | $77.8M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $64.6M |
负债/权益比ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $570.0K |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPIMRAM
| Q1 26 | — | $570.0K | ||
| Q4 25 | $-37.8M | $2.6M | ||
| Q3 25 | $-8.9M | $881.0K | ||
| Q2 25 | — | $5.0M | ||
| Q1 25 | — | $1.4M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $1.7M |
自由现金流ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | $-47.4M | $-975.0K | ||
| Q3 25 | $-12.0M | $543.0K | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $527.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $1.7M |
自由现金流率ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | -284.7% | -6.6% | ||
| Q3 25 | -245.5% | 3.9% | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 15.9% |
资本支出强度ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | 57.9% | 24.3% | ||
| Q3 25 | 64.4% | 2.4% | ||
| Q2 25 | — | 15.1% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% |
现金转化率ASPIMRAM
| Q1 26 | — | — | ||
| Q4 25 | — | 2.19× | ||
| Q3 25 | — | 16.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.16× | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
MRAM
| Product sales | $14.1M | 95% |
| Licensing, royalty, patent, engineering services and other revenue | $772.0K | 5% |
